Keywords
core outcome sets, systematic reviews, Cochrane, outcome choice, barriers, facilitators
This article is included in the Research on Research, Policy & Culture gateway.
core outcome sets, systematic reviews, Cochrane, outcome choice, barriers, facilitators
We have made various editorial changes, such as fixing typos and clarifying the language. We have clarified the exclusion criteria for reviews. We have made the language of the barriers and facilitators consistent.
See the authors' detailed response to the review by Roger Chou
See the authors' detailed response to the review by Theresa Sipe
Core outcome sets (COS) represent agreed-upon minimum outcomes that should be reported in all research studies in a given topic area.1 COS are intended to increase the usefulness of research evidence and facilitate comparisons across studies. Although COS have traditionally been developed for use in clinical trials, increasingly COS are also developed for routine care or for registries.2,3 A systematic review (SR) is a research effort whose goal is to identify and synthesize all relevant studies that fulfill pre-specified eligibility criteria to answer a specific research question(s).4,5 Thus, systematic reviewers not only evaluate primary research that should have considered COS6 but they should themselves also consider COS when choosing outcomes for the SR.
Cochrane SRs are considered among the most rigorously conducted SRs in the world.7–9 We previously conducted an analysis and reported that only seven of the first 100 published Cochrane SRs in 2019 (7%) cited a COS in relation to choosing outcomes.10 A relevant COS existed but was not mentioned (or cited) for 27 of the remaining 93 SRs (29%). For a further 6 reviews, a relevant COS was published after the protocol of the SR was developed.10 We similarly conducted an analysis of all 67 comparative effectiveness SRs that were published between 2018 and 2020 by Evidence-based Practice Centers (EPCs) with funding from the U.S. Agency for Healthcare Research and Quality (AHRQ) (EPC SRs are also highly rigorous SRs).11 We found relevant COS for 36 of the 67 EPC SRs (54%).11 In the Cochrane analysis paper, we also reported results of a survey of editors of 36 (of the then 52) Cochrane Review Groups; most editors (31/36; 86%) felt that COS should definitely/possibly be used in Cochrane SRs.10
Considerations regarding COS scope and contextual relevance to the SR notwithstanding, COS should be considered when choosing outcomes to be examined in SRs.11 Use of existing COS represents an opportunity for systematic reviewers to leverage the efforts of COS developers in identifying outcomes for their SRs. Indeed, the 2nd (i.e., most recent) edition of the Cochrane Handbook for Systematic Reviews of Interventions now recommends that SR teams consult resources that host relevant COS when choosing outcomes for the review.12 However, this edition of the Handbook was first published in September 2019, which was after outcome choices were made for all SRs in the sample of Cochrane SRs published in 2019 that we analyzed. Therefore, we do not know the extent to which authors of recent Cochrane SRs (and protocols) are considering COS to inform choice of outcomes.
Use of COS to inform choice of outcomes can be considered a behavior.13 In 2022, based on a survey of authors of clinical trials submitted to the top five medical journals (in terms of impact factor), Matvienko-Sikar and colleagues reported that the most common barrier to COS use was trialist preferences and choices regarding outcomes (68% of respondents), and the most common facilitator was trialist awareness and knowledge about COS (90%).14 Also in 2022, Hughes and colleagues conducted qualitative interviews of clinical trialists in the UK and reported that the biggest barriers to COS uptake were trialist perceptions regarding COS characteristics (e.g., increased patient burden, COS being out of date) and the COS development process (e.g., the lack of inclusion of all relevant clinical specialties).15 The biggest facilitators were trialist awareness and understanding of COS and funder and journal editor recommendations to use COS.15
Outcomes chosen for trials and for SRs, even within the same topic area, have been shown sometimes to be inconsistent, perhaps reflecting differing priorities.16,17 Moreover, for Cochrane SRs, these decisions are often shared between the authors and the editorial team (with input from the peer reviewers, including people with lived experience of the condition of interest).10 It may be that these various parties have different priorities, although the SR authors are primarily responsible for choosing which outcomes to assess and this will likely influence the final set of outcomes for a Cochrane SR. The stages of protocol development and subsequent peer review help vet the choice of outcomes.
We are aware of two surveys assessing barriers to COS use by SR authors, specifically in the topic area of pain.18,19 Boric and colleagues surveyed authors of SRs of interventions for neuropathic pain and reported that the main barrier to use of the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) COS was the lack of awareness of the full COS.18 Similarly, Dosenovic and colleagues surveyed authors of SRs of interventions for postoperative pain in children and reported that the main barriers to use of the pediatric version of the IMMPACT COS (PedIMMPACT) were the lack of awareness, difficulties with implementation, and the lack of resources.19
To our knowledge, the barriers and facilitators of use of COS have not been examined among Cochrane SR authors. In our previous analyses of Cochrane SRs and EPC SRs, we did not survey the authors. The insights that could be gained from such an examination would be crucial to inform approaches to increasing awareness and uptake of COS in future SRs, both within and beyond Cochrane.
For Objective 1, we will conduct a cross-sectional analysis of recent Cochrane SRs to examine the extent to which they (a) cited a COS, (b) mentioned searching for COS, and (c) reported outcome inconsistency among included studies and/or noted the need for COS. For Objective 2, we will conduct an online survey of authors of these recent Cochrane SRs to identify barriers and facilitators of their using COS to inform outcome choice in SRs.
Eligibility Criteria for Cochrane SRs: We will include all completed Cochrane SRs published in the last 3 months of 2022 and all Cochrane SR protocols published throughout 2022 that evaluate intervention effectiveness and/or harms. This period restriction will enable us to examine contemporary practices regarding outcome choice in Cochrane SRs. We will not restrict SRs or protocols by topic area or location of the authors or Cochrane Review Group. We will exclude SRs of qualitative studies, SRs of methodological topics, and SRs that only address prognosis, diagnostic accuracy, or etiology. A total of 294 SRs are eligible for Objective 1.
Identifying Cochrane SRs: We will identify relevant completed SRs and protocols by searching the Cochrane Database of Systematic Reviews through the Cochrane Library, restricting by the periods of interest.
Data extraction:
For all relevant SRs, we will extract information about whether the SR authors:
(1) Cited a COS in the context of choosing outcomes for the review, and
(2) Mentioned having searched for a COS to choose outcomes for the review.
For completed SRs only, we will extract information about whether the SR authors:
(3) Noted any problems with outcome inconsistency across the included studies and/or the need for outcome standardization/COS development.
For all SRs that cited or mentioned using a COS, and SRs that did not cite a COS but for which we found one, we will also extract:
(4) The extent to which the SR authors used outcomes from the COS. In other words, we will assess the extent of overlap between the COS outcomes and the SR outcomes using a framework that we developed11 and has been used since then.20 Briefly, we will focus on the outcome domains (the “what,” e.g., pain) but will not examine whether the “how” of the outcome (e.g., one instrument for measuring pain versus another) matched. The framework we developed considers matches to be general (i.e., nonspecific) or specific. Our approach to determining the type of match for pairs of outcomes is consistent with an approach that has been used previously.2,20,21
For SRs that did not cite or mention having considered a COS (i.e., no to both #1 and #2 above), we will also extract whether:
(5) A relevant COS exists. We will do this by searching the Core Outcome Measures for Effectiveness Trials (COMET) database. Maintained by the COMET Initiative, this is a free, online, regularly updated, searchable database of COS. One investigator will assess the potential relevance of each identified COS to the topic of each SR following an approach used previously.10,20,22 For identified COS, we will also extract information regarding when the COS was published. This will allow us to assess whether the COS was available during the stage of outcome choice for the SR/protocol.
For information extraction, we will review all sections of the SR/protocol report. One investigator will extract information from each SR/protocol and a second investigator will independently verify the extracted information.
Statistical analysis: We will calculate descriptive statistics (percentages and medians with 25th and 75th percentiles). We will conduct all data analyses using Stata Version 16 (College Station, Texas, USA).
Eligibility Criteria for Cochrane SR authors: We will email a survey to the corresponding authors of all completed relevant Cochrane protocols and completed SRs from Objective 1. If a corresponding author does not respond to the survey or our email, we will send the survey to the senior (i.e., last) author. If similar nonresponse occurs, we will send the survey to another author from the author list (e.g., first author). At each request, we will suggest that the person(s) most familiar with the considerations during outcome choice for the SR complete a single survey for the SR.
Survey design and implementation: We will design and distribute the survey using Jisc Online Surveys® in English. We will send the author(s) of each relevant SR one of four versions of the survey:
• Version A: For SRs that cited/mentioned searching for a COS and the full COS was used.
• Version B: For SRs that cited/mentioned searching for a COS and some but not all COS outcomes were used.
• Version C: For SRs that did not cite/mention searching for a COS, but we identified a potentially relevant COS that could have been used.
• Version D: For SRs that did not cite/mention searching for a COS and we did not identify a potentially relevant COS that could have been used.
Items of interest for the surveys include:
1. Author process for outcome choice for the SR
2. Awareness of COS in general
3. Whether the authors searched for COS (regardless of whether the SR mentions that the authors searched for it)
4. Awareness of a relevant COS (if one exists for the SR)
5. Reasons for non-use of relevant COS (if one exists for the SR)
6. Perceived barriers to COS use
7. Perceived facilitators of COS use.
For items 5, 6, and 7 above, Box 1 lists examples of prespecified as well as open-ended response options.
Institutional Review Board (IRB) approval: Before we distribute the surveys, we will obtain Research Ethics Committee approval from the University of Liverpool, UK.
Data analysis: We will analyze the data by calculating descriptive statistics. For open-ended responses to the survey, we will use content analysis. For overlapping questions across versions of the survey, we will analyze and report overall results as well as separate results by survey version. We will report information from the survey only in the aggregate.
Use of COS in Cochrane SRs is important to improve outcome standardization, reduce research waste, and improve evidence synthesis regarding the effects of interventions in particular health areas. A possible limitation of the current study’s findings (if the survey response rate is poor) is that the findings may not be generalizable to all current Cochrane reviewers. However, it is expected that this study will provide useful findings regarding the extent of uptake of COS by Cochrane reviewers and key insights regarding author views and reasons for using, or not using, COS when deciding on outcomes for Cochrane SRs. The findings and insights are essential to better understand barriers and facilitators of COS uptake in Cochrane SRs, so that interventions to promote uptake can be developed and improved.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Systematic reviews
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Methods for systematic reviews and efficacy reviews that identify individual evidence-based interventions, HIV prevention.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Partly
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Systematic reviews and systematic review methods
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Partly
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Methods for systematic reviews and efficacy reviews that identify individual evidence-based interventions, HIV prevention.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 2 (revision) 25 Sep 23 |
read | read | |
Version 1 23 Jun 23 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)